Cui Xiaotian

1 month ago | caixinglobal.com | Cui Xiaotian |Denise Jia

China has banned Illumina, the U.S. genomics giant, from exporting gene sequencing machines to the country, escalating sanctions imposed last month when the company was added to Beijing’s Unreliable Entity List. The move is expected to accelerate domestic alternatives in the gene sequencing industry. Illumina, a dominant player in the global gene sequencing industry, has been a major supplier in China since entering the market in 2005.

1 month ago | caixinglobal.com | Cui Xiaotian |Denise Jia

China has banned Illumina, the U.S. genomics giant, from exporting gene sequencing machines to the country, escalating sanctions imposed last month when the company was added to Beijing’s Unreliable Entity List. The move is expected to accelerate domestic alternatives in the gene sequencing industry. Illumina, a dominant player in the global gene sequencing industry, has been a major supplier in China since entering the market in 2005.

2 months ago | caixinglobal.com | Cui Xiaotian |Kelly Wang

00:00/00:00 您的浏览器不支持 audio 标签。 Listen to this article 1x New data discrepancies involving generic drug approvals in China have added to concerns that led a national regulator to suspend public access to the information for more than two weeks earlier this year to correct the problems. Statistical errors persist in the restored Center for Drug Evaluation (CDE) data, and problems with the drug approval data submission process have surfaced as an issue, Caixin has learned.

2 months ago | caixinglobal.com | Cui Xiaotian |Kelly Wang

00:00/00:00 您的浏览器不支持 audio 标签。 Listen to this article 1x New data discrepancies involving generic drug approvals in China have added to concerns that led a national regulator to suspend public access to the information for more than two weeks earlier this year to correct the problems.

2 months ago | caixinglobal.com | Zhou Xinda |Cui Xiaotian |Jiang Moting |Kelly Wang

Personalised advertising and content, advertising and content measurement, audience research and services developmentStore and/or access information on a deviceYou can choose how your personal data is used.